Mumbai, India

Rhushikesh Arun Kulkarni

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Piramal Healthcare Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rhushikesh Arun Kulkarni. Retrieved from https://idiyas.com/inventor/rhushikesh-arun-kulkarni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rhushikesh Arun Kulkarni: Innovator in Metabolic Disorder Treatments

Introduction

Rhushikesh Arun Kulkarni is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic disorders. His innovative work has the potential to impact many lives positively.

Latest Patents

Kulkarni holds a patent for "3-amino-pyridine derivatives for the treatment of metabolic disorders." This invention provides novel compounds represented by the general formula (I), along with their pharmaceutically acceptable salts and solvates. These compounds are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. The patent also details a process for manufacturing these compounds and pharmaceutical compositions containing them.

Career Highlights

Kulkarni is currently employed at Piramal Healthcare Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in his field.

Collaborations

Some of his coworkers include Nabajyoti Deka and Kamlesh Jyotindra Padiya, who contribute to the collaborative efforts in their projects.

Conclusion

Rhushikesh Arun Kulkarni's work in developing treatments for metabolic disorders showcases his commitment to innovation in healthcare. His contributions are paving the way for advancements in pharmaceutical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…